Detailed evaluation on the effect of metal ion impurities on complexation of generator eluted 68Ga with different bifunctional chelators
Description
Introduction: The introduction of 68Ga-based positron emission tomography (PET) to clinical practice using 68Ge/68Ga generator represents a developmental milestone in the field of molecular imaging. Herein, we report a systematic study on 68Ga complexes with different bifunctional chelators (BFCs) and the effect of metal ion impurities on the radiochemical yields in order to identify the most suitable BFC to be used for the development of 68Ga-based target specific radiopharmaceuticals. Methods: Radiolabeling of four commonly used BFCs namely p-isothiocyanato benzyl derivatives of diethylenetriaminepentacetic acid (DTPA), 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) and 3,6,9,15-tetraazabicyclo [9.3.1]pentadeca-1(15),11,13-triene-3,6,9-triacetic acid (PCTA) with 68Ga was studied with respect to optimal radiolabeling conditions, effect of metal ion impurities on radiochemical yield, in vitro stability and in vivo clearance properties in biological system. Results: Out of the four BFCs studied, p-isothiocyanato benzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA-NCS) could be radiolabeled instantly with 68Ga at room temperature with > 98% yield, even in presence of up to 10 ppm of other metal ion impurities (such as Zn, Cu, Fe, Al, Sn and Ti ions). The 68Ga-complex of NOTA-NCS demonstrated high in vitro stability even in the presence of 1000 times molar excess of metal ions (such as Fe, Cu, Zn and Ca ions). In contrast, other 68Ga-labeled BFCs (DTPA-NCS, DOTA-NCS and PCTA-NCS) showed reduced radiochemical yields when incubated with the above concentration of metal ions. The biodistribution studies in Swiss mice revealed that 68Ga-NOTA-NCS cleared rapidly through the kidneys with minimum retention in any major organ. Conclusions: The simple and rapid approach for preparation of 68Ga-radiopharmaceuticals using NOTA based bifunctional chelators would render 68Ga-radiopharmaceutical chemistry more convenient with minimum interference from other metal ion impurities; and increase the scope of making 68Ga based agents for PET imaging
Availability note (English)
Available from http://dx.doi.org/10.1016/j.nucmedbio.2012.11.001Additional details
Identifiers
- DOI
- 10.1016/j.nucmedbio.2012.11.001;
- PII
- S0969-8051(12)00275-2;
Publishing Information
- Journal Title
- Nuclear Medicine and Biology
- Journal Volume
- 40
- Journal Issue
- 2
- Journal Page Range
- p. 197-205
- ISSN
- 0969-8051
- CODEN
- NMBIEO
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 45083547
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- DTPA; GALLIUM 68; GERMANIUM 68; IMPURITIES; IN VITRO; IN VIVO; IONS; METALS; MICE; POSITRON COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RENAL CLEARANCE
- Descriptors DEC
- AMINO ACIDS; ANIMALS; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; CARBOXYLIC ACIDS; CHARGED PARTICLES; CHELATING AGENTS; CLEARANCE; COMPUTERIZED TOMOGRAPHY; DAYS LIVING RADIOISOTOPES; DIAGNOSTIC TECHNIQUES; DRUGS; ELECTRON CAPTURE RADIOISOTOPES; ELEMENTS; EMISSION COMPUTED TOMOGRAPHY; EVEN-EVEN NUCLEI; EXCRETION; GALLIUM ISOTOPES; GERMANIUM ISOTOPES; HOURS LIVING RADIOISOTOPES; INTERMEDIATE MASS NUCLEI; ISOTOPES; LABELLED COMPOUNDS; MAMMALS; MATERIALS; NUCLEI; ODD-ODD NUCLEI; ORGANIC ACIDS; ORGANIC COMPOUNDS; RADIOACTIVE MATERIALS; RADIOISOTOPES; RADIOPROTECTIVE SUBSTANCES; RESPONSE MODIFYING FACTORS; RODENTS; TOMOGRAPHY; VERTEBRATES
Optional Information
- Copyright
- Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.